Emma Reeve - 12 Jun 2025 Form 4 Insider Report for Whitehawk Therapeutics, Inc. (WHWK)

Role
Director
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol
WHWK
Transactions as of
12 Jun 2025
Transactions value $
$0
Form type
4
Filing time
16 Jun 2025, 16:54:40 UTC
Previous filing
07 Jan 2025
Next filing
16 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reeve Emma Director C/O WHITEHAWK THERAPEUTICS, INC., MORRISTOWN /s/ Stephen Rodin, as Attorney-in-Fact 16 Jun 2025 0001680329

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WHWK Stock Option (right to buy) Award $0 +40,006 $0 40,006 12 Jun 2025 Common Stock 40,006 $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2025.

Remarks:

Exhibit 24 - Power of Attorney